Home


In millions, except shares and per share amounts January 1,
2000
  December 26,
1998

Assets:
   Cash and cash equivalents $230.0 $180.8
   Accounts receivable, net 699.3 650.3
   Inventories 3,445.5 3,190.2
   Deferred income taxes 139.4 248.7
   Other current assets 93.8 79.2

      Total current assets

4,608.0 4,349.2
   Property and equipment, net 1,601.0 1,351.2
   Goodwill, net 706.9 724.6
   Other assets 359.5 261.2

      Total assets $7,275.4 $6,686.2

Liabilities:
   Accounts payable $1,454.2 $1,286.3
   Accrued expenses 967.4 1,061.3
   Short-term borrowings 451.0 771.1
   Current portion of long-term debt 17.3 14.6

      Total current liabilities

2,889.9 3,133.3
   Long-term debt 558.5 275.7
   Deferred income taxes 27.2 24.3
   Other long-term liabilities

120.1 142.3
   Commitments and contingencies (Note 12)

Shareholders’ equity:

   Preferred stock, $0.01 par value: authorized 120,619 shares;
      no shares issued or outstanding
   Preference stock, series one ESOP convertible, par value $1.00:
      authorized 50,000,000 shares; issued and outstanding 5,164,000 shares
      at January 1, 2000, and 5,239,000 shares at December 26, 1998
276.0 280.0
   Common stock, par value $0.01: authorized 1,000,000,000 shares;
      issued 403,047,000 shares at January 1, 2000, and
      401,380,000 shares at December 26, 1998
4.0 4.0
   Treasury stock, at cost: 11,051,000 shares at January 1, 2000, and
      11,169,000 shares at December 26, 1998
(258.5) (260.2)
   Guaranteed ESOP obligation (257.0) (270.7)
   Capital surplus 1,371.7 1,336.4
   Retained earnings 2,543.5 2,021.1

      Total shareholders’ equity 3,679.7 3,110.6

      Total liabilities and shareholders’ equity $7,275.4 $6,686.2

See accompanying notes to consolidated financial statements.

Download this section in PDF format.

home

copyright 1999 CVS/pharmacy, Inc.
For Investor web site questions/comments, send e-mail to investorinfo@cvs.com